INO
INO
US45773H4092
Inovio Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
118.91M EUR
90.58M EUR
121.41M EUR
120.05M EUR
Enterprise Value
84.03M EUR
67.05M EUR
103.83M EUR
85.15M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-2.61x
--
--
--
Price to Sales
-
--
--
--
Price to Book
21.7x
20.72x
20.01x
4.98x
EV/Revenue
--
--
--
--
EV/EBITDA
-1.08x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-28.47%
-89.18%
-68.84%
-51.63%
ende